ES2299871T3 - Tratamiento pre-operatorio del dolor post-operatorio. - Google Patents

Tratamiento pre-operatorio del dolor post-operatorio. Download PDF

Info

Publication number
ES2299871T3
ES2299871T3 ES04779185T ES04779185T ES2299871T3 ES 2299871 T3 ES2299871 T3 ES 2299871T3 ES 04779185 T ES04779185 T ES 04779185T ES 04779185 T ES04779185 T ES 04779185T ES 2299871 T3 ES2299871 T3 ES 2299871T3
Authority
ES
Spain
Prior art keywords
buprenorphine
dosage
transdermal
surgery
dosage form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES04779185T
Other languages
English (en)
Spanish (es)
Inventor
Bruce E. Reidenberg
Daniel A. Spyker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Application granted granted Critical
Publication of ES2299871T3 publication Critical patent/ES2299871T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Processing Of Meat And Fish (AREA)
ES04779185T 2003-07-25 2004-07-26 Tratamiento pre-operatorio del dolor post-operatorio. Expired - Lifetime ES2299871T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49036303P 2003-07-25 2003-07-25
US490363P 2003-07-25

Publications (1)

Publication Number Publication Date
ES2299871T3 true ES2299871T3 (es) 2008-06-01

Family

ID=34115386

Family Applications (1)

Application Number Title Priority Date Filing Date
ES04779185T Expired - Lifetime ES2299871T3 (es) 2003-07-25 2004-07-26 Tratamiento pre-operatorio del dolor post-operatorio.

Country Status (27)

Country Link
US (3) US20080026042A1 (enExample)
EP (1) EP1638492B1 (enExample)
JP (1) JP5632573B2 (enExample)
KR (4) KR20080011248A (enExample)
CN (1) CN1829489B (enExample)
AT (1) ATE382354T1 (enExample)
AU (1) AU2004261181B2 (enExample)
BR (1) BRPI0412924A (enExample)
CA (1) CA2529983C (enExample)
CY (1) CY1107352T1 (enExample)
DE (1) DE602004011055T2 (enExample)
DK (1) DK1638492T3 (enExample)
EA (1) EA009213B1 (enExample)
ES (1) ES2299871T3 (enExample)
GE (1) GEP201606538B (enExample)
HR (1) HRP20080146T3 (enExample)
IL (1) IL173345A (enExample)
IS (1) IS8186A (enExample)
MA (1) MA28005A1 (enExample)
MX (1) MXPA06000990A (enExample)
NO (1) NO326636B1 (enExample)
NZ (1) NZ594154A (enExample)
PL (1) PL1638492T3 (enExample)
PT (1) PT1638492E (enExample)
UA (1) UA81689C2 (enExample)
WO (1) WO2005011578A2 (enExample)
ZA (1) ZA200510071B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DE10361306A1 (de) * 2003-12-24 2005-07-28 Lts Lohmann Therapie-Systeme Ag Wundauflage und Wundschnellverband mit einem vasokonstriktorischen Inhaltsstoff, sowie Herstellungsverfahren hierfür
JP2011251944A (ja) * 2010-06-02 2011-12-15 Kansai Medical Univ 埋植用鎮痛製剤
DE102010024105A1 (de) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
ES2688577T3 (es) 2010-09-03 2018-11-05 Zoetis Belgium S.A. Composiciones de buprenorfina en dosis altas y uso como analgésico
RU2459640C2 (ru) * 2010-10-26 2012-08-27 Государственное учреждение здравоохранения "Воронежская областная клиническая больница № 1" Способ послеоперационного обезболивания больных, оперированных под спинальной анестезией
RU2487734C1 (ru) * 2011-11-17 2013-07-20 Анатолий Анатольевич Лаврентьев Способ послеоперационного обезболивания
RU178867U1 (ru) * 2016-05-04 2018-04-20 Общество с ограниченной ответственностью Научно-производственное предприятие "НОК" Вакуумная микроразмерная кристаллизационная ячейка
RU2649961C1 (ru) * 2017-02-28 2018-04-05 Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) Способ обезболивания после проведения операции кесарева сечения у пациенток с избыточной массой тела
WO2024055006A2 (en) * 2022-09-09 2024-03-14 The Regents Of The University Of California Compositions for preventing transition from acute to chronic pain

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4119713A (en) * 1977-02-09 1978-10-10 Sam Carosio Analgesic and anti-inflammatory composition
US4806341A (en) * 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
US5026556A (en) * 1988-11-10 1991-06-25 Norwich Eaton Pharmaceuticals, Inc. Compositions for the transdermal delivery of pharmaceutical actives
US5240711A (en) * 1989-11-29 1993-08-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising as active component buprenorphine
DK0484543T3 (da) * 1990-04-24 1996-01-22 Teijin Ltd Plaster
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
SE9003665D0 (sv) * 1990-11-16 1990-11-16 Kabivitrum Ab Morphine prodrugs
JP2669951B2 (ja) * 1991-03-28 1997-10-29 雍憲 森本 麻薬性鎮痛剤を含有する経皮吸収組成物
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
CA2174803C (en) * 1996-04-23 2000-07-11 Jonathan P. Wong Use of liposome encapsulated ciprofloxacin as an immunotherapeutic drug
JPH1036265A (ja) * 1996-07-19 1998-02-10 Nitto Denko Corp ブプレノルフィン経皮吸収製剤
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US5942530A (en) * 1997-08-28 1999-08-24 Eli Lilly And Company Method for treating pain
KR100383252B1 (ko) * 1998-12-17 2003-07-16 주식회사 삼양사 부프레놀핀을함유하는경피투여조성물및이를포함하는패취
DE19901085C2 (de) * 1999-01-14 2003-12-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps
JP4659943B2 (ja) * 2000-02-25 2011-03-30 帝三製薬株式会社 塩酸ブプレノルフィン含有貼付剤
AU2001262683A1 (en) * 2000-06-02 2001-12-17 Teijin Limited Buprenorphine-containing patch
GB0026137D0 (en) * 2000-10-25 2000-12-13 Euro Celtique Sa Transdermal dosage form
US20020106407A1 (en) * 2000-12-11 2002-08-08 Dennis Coleman Method and apparatus for treating breakthrough pain
DK2113315T3 (da) * 2001-04-23 2014-08-18 Euro Celtique Sa Bortskaffelsessystem til transdermal doseringsform
PT2062573E (pt) * 2001-05-01 2012-01-11 Euro Celtique Sa Sistemas transdérmicos que contêm opióides que resistem a violação
DE60235159D1 (de) * 2001-05-22 2010-03-11 Euro Celtique Sa Behälter und verfahren zum abgeben transdermaler dosierungsformen
MXPA05006334A (es) * 2002-12-13 2005-08-26 Euro Celtique Sa Dosis de buprenorfina transdermica para analgesia.

Also Published As

Publication number Publication date
IS8186A (is) 2005-12-19
EP1638492B1 (en) 2008-01-02
EP1638492A2 (en) 2006-03-29
KR20120128715A (ko) 2012-11-27
HRP20080146T3 (en) 2008-04-30
CA2529983A1 (en) 2005-02-10
EA200600284A1 (ru) 2006-06-30
KR20080011248A (ko) 2008-01-31
CN1829489A (zh) 2006-09-06
MXPA06000990A (es) 2006-04-11
IL173345A0 (en) 2006-06-11
MA28005A1 (fr) 2006-07-03
GEP201606538B (en) 2016-09-12
JP5632573B2 (ja) 2014-11-26
ATE382354T1 (de) 2008-01-15
DE602004011055T2 (de) 2008-12-18
EP1638492A4 (en) 2006-07-19
AU2004261181B2 (en) 2009-08-06
KR20090031961A (ko) 2009-03-30
KR20060054346A (ko) 2006-05-22
CY1107352T1 (el) 2012-12-19
PT1638492E (pt) 2008-03-17
CN1829489B (zh) 2010-12-15
US20110002975A1 (en) 2011-01-06
HK1087907A1 (en) 2006-10-27
BRPI0412924A (pt) 2006-09-26
US20140221413A1 (en) 2014-08-07
WO2005011578A3 (en) 2005-09-09
NZ594154A (en) 2012-12-21
DE602004011055D1 (de) 2008-02-14
NO326636B1 (no) 2009-01-26
ZA200510071B (en) 2006-11-29
PL1638492T3 (pl) 2008-06-30
AU2004261181A1 (en) 2005-02-10
DK1638492T3 (da) 2008-05-13
EA009213B1 (ru) 2007-12-28
WO2005011578A2 (en) 2005-02-10
JP2007500133A (ja) 2007-01-11
NO20060912L (no) 2006-04-21
CA2529983C (en) 2010-07-20
IL173345A (en) 2010-06-16
UA81689C2 (ru) 2008-01-25
US20080026042A1 (en) 2008-01-31

Similar Documents

Publication Publication Date Title
ES2295929T3 (es) Tratamiento de suspension de la dependencia.
US20110002975A1 (en) Preoperative treatment of post operative pain
PT1485051E (pt) Processo de administração da buprenorfina para o tratamento da depressão
US7413748B2 (en) Transdermal buprenorphine to treat pain in sickle cell crisis
HK1087907B (en) Preoperative treatment of post operative pain